Clinical Trials in Baltimore

Showing 8601-8620 of 23,476 trials

Ketamine for OUD and Comorbid Depression (OUDCD)

NCT05051449

Methadone is a first-line, evidence-based treatment for opioid use disorder (OUD). Unfortunately, retention and adherence in methadone treatment is a major challenge. OUD patients frequently present with co-morbid depression (OUDCD), a risk factor for poor OUD treatment outcomes, overdose, and suicide. The last two decades have seen an exciting and transformational development in the treatment of depression - ketamine. As a safe, rapid-acting anti-depressant deliverable within the context of methadone maintenance treatment, ketamine could feasibly change the landscape of treatment for OUD patients with comorbid depression. This proposal seeks to evaluate implementation outcomes (feasibility and patient acceptance) as well as preliminary efficacy of ketamine on methadone treatment outcomes for OUD patients (n=6) with comorbid depression and depressive symptoms presenting for methadone treatment.

Opioid Use DisorderDepressive Disorder

University of Maryland, Baltimore5 participantsStarted Apr 2022

Baltimore, Maryland, United States

COMPLETED8.9 miles

A Clinical Utility Study of PrismRA for Rheumatoid Arthritis

NCT05161234

A clinical utility study for PrismRA testing therapeutic response in patients with rheumatoid arthritis.

Rheumatoid Arthritis

Scipher Medicine613 participantsStarted Mar 2022

Chandler, Arizona, United States • Covina, California, United States • Hemet, California, United States +27 more locations

Ketamine for OUD and Comorbid Depression (OUDCD)

A Clinical Utility Study of PrismRA for Rheumatoid Arthritis

Find Trials by Condition in Baltimore

[11C]-(R)-Rolipram to Measure cAMP Signaling Before and After Ketamine

DeepView SnapShot Portable (DV-SSP): Device Training Study

A Multicenter, Multinational, Observational Morquio A Registry Study (MARS)

A Safety and Tolerability Study of NC318 in Subjects With Advanced or Metastatic Solid Tumors

Perceval Sutureless Implant Versus Standard-Aortic Valve Replacement

CORCYM Mitral, Aortic aNd Tricuspid Post-maRket Study in a reAl-world Setting

A Comparison of DFD01 Spray Versus Vehicle Spray in Subjects With Moderate Psoriasis

On-X Heart Valve - 17mm Aortic and 23mm Mitral

A Study of JNJ-73763989, Pegylated Interferon Alpha-2a and Nucleos(t)Ide Analogs in Participants With Chronic Hepatitis B Virus Infection

Training Programs to Improve Outcomes for Individuals With Spinal Cord Injury

Epithelioid Sarcoma Natural History Study

DFD01 Spray HPA Axis Suppression Study in Adolescent Patients With Moderate to Severe Plaque Psoriasis

Control-IQ Technology in Individuals With Type 2 Diabetes

Sorin Universal REgistry on Aortic Valve Replacement

LGX818 and MEK162 in Combination With a Third Agent (BKM120, LEE011, BGJ398 or INC280) in Advanced BRAF Melanoma

BMS-986012 in Relapsed/Refractory SCLC

A Study on Patients With Chronic Kidney Disease (CKD) to Assess Treatment Experience and Patterns, Effect of the Treatment, Patient Outcomes and Patient Quality of Life

DCBY02 as a Monotherapy in Patients With Advanced or Metastatic Solid Tumors